Haloperidol and clozapine differentially affect the expression of arrestins, receptor kinases, and extracellular signal-regulated kinase activation

Journal of Pharmacology and Experimental Therapeutics

Volumn 325, Issue 1, 2008, Pages 276-283

  Ahmed, Mohamed Rafiuddin ^a   Gurevich, Vsevolod V ^a   Dalby, Kevin N ^b   Benovic, Jeffrey L ^c   Gurevich, Eugenia V ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARRESTIN2; CLOZAPINE; G PROTEIN COUPLED RECEPTOR KINASE; G PROTEIN COUPLED RECEPTOR KINASE 2; G PROTEIN COUPLED RECEPTOR KINASE 3; G PROTEIN COUPLED RECEPTOR KINASE 5; HALOPERIDOL; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN DERIVATIVE; RETINA S ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CAUDATE NUCLEUS; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; GLOBUS PALLIDUS; HIPPOCAMPUS; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUTAMEN; RAT; SIGNAL TRANSDUCTION;

ANIMALS; ARRESTINS; BRAIN; BRAIN CHEMISTRY; CLOZAPINE; CRYOULTRAMICROTOMY; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; G-PROTEIN-COUPLED RECEPTOR KINASE 2; G-PROTEIN-COUPLED RECEPTOR KINASE 3; G-PROTEIN-COUPLED RECEPTOR KINASE 5; G-PROTEIN-COUPLED RECEPTOR KINASES; GENE EXPRESSION; HALOPERIDOL; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 41149167191     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.107.131987     Document Type: Article

References (40)

1. Abi-Dargham A and Laruelle M (2005) Mechanisms of action of second generation antipsychotic drugs in schizophrenia: insights from brain imaging studies. Eur Psychiatry 20:15-27.
2. Ahmed MR, Bychkov ER, Gurevich VV, Benovic JL, and Gurevich EV (2007) Altered expression and subcellular distribution of GRK subtypes in the dopamine-depleted rat basal ganglia is not normalized by L-DOPA treatment. J Neurochem, in press.
3. Ahn S, Nelson CD, Garrison TR, Miller WE, and Lefkowitz RJ (2003) Desensitization, internalization, and signaling functions of beta-arrestins demonstrated by RNA interference. Proc Natl Acad Sci U S A 100:1740-1744.
4. Alimohamad H, Rajakumar N, Seah YH, and Rushlow W (2005) Antipsychotics alter the protein expression levels of beta-catenin and GSK-3 in the rat medial prefrontal cortex and striatum. Biol Psychiatry 57:533-542.
5. Baldessarini RJ, Centorrino F, Flood JG, Volpicelli SA, Huston-Lyons D, and Cohen BM (1993) Tissue concentrations of clozapine and its metabolites in the rat. Neuropsychopharmacology 9:117-124.
6. Bohn LM, Gainetdinov RR, Sotnikova TD, Medvedev IO, Lefkowitz RJ, Dykstra LA, and Caron MG (2003) Enhanced rewarding properties of morphine, but not cocaine, in beta(arrestin)-2 knock-out mice. J Neurosci 23:10265-10273.
7. Browning JL, Patel T, Brandt PC, Young KA, Holcomb LA, and Hicks PB (2005) Clozapine and the mitogen-activated protein kinase signal transduction pathway: implications for antipsychotic actions. Biol Psychiatry 57:617-623.
8. Burnet PW, Chen CP, McGowan S, Franklin M, and Harrison PJ (1996) The effects of clozapine and haloperidol on serotonin-1A, -2A and -2C receptor gene expression and serotonin metabolism in the rat forebrain. Neuroscience 73:531-540.
9. Díaz A, Pazos A, Florez J, Ayesta FJ, Santana V, and Hurle MA (2002) Regulation of mu-opioid receptors, G-protein-coupled receptor kinases and beta-arrestin 2 in the rat brain after chronic opioid receptor antagonism. Neuroscience 112:345-353.
10. Dwivedi Y, Rizavi HS, and Pandey GN (2002) Differential effects of haloperidol and clozapine on [(3)H]cAMP binding, protein kinase A (PKA) activity, and mRNA and protein expression of selective regulatory and catalytic subunit isoforms of PKA in rat brain. J Pharmacol Exp Ther 301:197-209.
11. Fan X, Zhang J, Zhang X, Yue W, and Ma L (2002) Acute and chronic morphine treatments and morphine withdrawal differentially regulate GRK2 and GRK5 gene expression in rat brain. Neuropharmacology 43:809-816.
12. Frost DO, Tamminga CA, Medoff DR, Caviness V, Innocenti G, and Carpenter WT (2004) Neuroplasticity and schizophrenia. Biol Psychiatry 56:540-543.
13. Fumagalli F, Frasca A, Spartà M, Drago F, Racagni G, and Riva MA (2006) Long-term exposure to the atypical antipsychotic olanzapine differently up-regulates extracellular signal-regulated kinases 1 and 2 phosphorylation in subcellular compartments of rat prefrontal cortex. Mol Pharmacol 69:1366-1372.
14. Gainetdinov RR, Premont RT, Bohn LM, Lefkowitz RJ, and Caron MG (2004) Desensitization of G protein-coupled receptors and neuronal function. Annu Rev Neurosci 27:107-144.
15. Gurevich EV, Benovic JL, and Gurevich VV (2002) Arrestin2 and arrestin3 are differentially expressed in the rat brain during postnatal development. Neuroscience 109:421-436.
16. Gurevich EV, Benovic JL, and Gurevich VV (2004) Arrestin2 expression selectively increases during neural differentiation. J Neurochem 91:1404-1416.
17. Gurevich VV and Gurevich EV (2006) The structural basis of arrestin-mediated regulation of G-protein-coupled receptors. Pharmacol Ther 110:465-502.
18. Hurlé MA (2001) Changes in the expression of G protein-coupled receptor kinases and beta-arrestin 2 in rat brain during opioid tolerance and supersensitivity. J Neurochem 77:486-492.
19. Ichikawa J, Dai J, O'Laughlin IA, Fowler WL, and Meltzer HY (2002) Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum. Neuropsychopharmacology 26:325-339.
20. Kapur S, VanderSpek SC, Brownlee BA, and Nobrega JN (2003) Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy. J Pharmacol Exp Ther 305:625-631.
21. Kim KM, Valenzano KJ, Robinson SR, Yao WD, Barak LS, and Caron MG (2001) Differential regulation of the dopamine D2 and D3 receptors by G protein-coupled receptor kinases and beta-arrestins. J Biol Chem 276:37409-37414.
22. Lefkowitz RJ and Whalen EJ (2004) Beta-arrestins: traffic cops of cell signaling. Curr Opin Cell Biol 16:162-168.
23. Maheux J, Ethier I, Rouillard C, and Levesque D (2005) Induction patterns of transcription factors of the nur family (nurr1, nur77, and nor-1) by typical and atypical antipsychotics in the mouse brain: implication for their mechanism of action. J Pharmacol Exp Ther 313:460-473.
24. McClung CA, Ulery PG, Perrotti LI, Zachariou V, Berton O, and Nestler EJ (2004) DeltaFosB: a molecular switch for long-term adaptation in the brain. Brain Res Mol Brain Res 132:146-154.
25. Meltzer HY (2004) What's atypical about atypical antipsychotic drugs? Curr Opin Pharmacol 4:53-57.
26. Merchant KM, Dobie DJ, Filloux FM, Totzke M, Aravagiri M, and Dorsa DM (1994) Effects of chronic haloperidol and clozapine treatment on neurotensin and c-fos mRNA in rat neostriatal subregions. J Pharmacol Exp Ther 27:460-471.
27. Miralles A, Asensio VJ, and Garcia-Sevilla JA (2002) Acute treatment with the cyclic antidepressant desipramine, but not fluoxetine, increases membrane-associated G protein-coupled receptor kinases 2/3 in rat brain. Neuropharmacology 43:1249-1257.
28. Miyamoto S, Duncan GE, Marx CE, and Lieberman JA (2005) Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs Mol Psychiatry 10:79-104.
29. Pan L, Gurevich EV, and Gurevich VV (2003) The nature of the arrestin x receptor complex determines the ultimate fate of the internalized receptor. J Biol Chem 278:11623-11632.
30. Paxinos G and Watson C (1998) The Rat Brain in Stereotaxic Coordinates, Academic Press, San Diego, CA.
31. Penela P, Ribas C, and Mayor FJ (2003) Mechanisms of regulation of the expression and function of G protein-coupled receptor kinases. Cell Signal 15:973-981.
32. Pira L, Mongeau R, and Pani L (2004) The atypical antipsychotic quetiapine increases both noradrenaline and dopamine release in the rat prefrontal cortex. Eur J Pharmacol 504:61-64.
33. Premont RT and Gainetdinov RR (2007) Physiological roles of G protein-coupled receptor kinases and arrestins. Annu Rev Physiol 69:511-534.
34. Roth BL, Sheffler DJ, and Kroeze WK (2004) Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia. Nat Rev Drug Discov 4:353-359.
35. Shenoy SK and Lefkowitz RJ (2003) Multifaceted roles of beta-arrestins in the regulation of seven-membrane-spanning receptor trafficking and signalling. Biochem J 375:503-515.
36. Singh RK, Shi J, Zemaitaitis BW, and Muma NA (2007) Olanzapine increases RGS7 protein expression via stimulation of the Janus tyrosine kinase-signal transducer and activator of transcription signaling cascade. J Pharmacol Exp Ther 322:133-140.
37. Steward L, Kennedy MD, Morris BJ, and Pratt JA (2004) The atypical antipsychotic drug clozapine enhances chronic PCP-induced regulation of prefrontal cortex 5-HT2A receptors. Neuropharmacology 47:527-537.
38. Tandon R and Jibson MD (2003) Efficacy of newer generation antipsychotics in the treatment of schizophrenia. Psychoneuroendocrinology 28:9-26.
39. Tohgo A, Pierce KL, Choy EW, Lefkowitz RJ, and Luttrell LM (2002) beta-Arrestin scaffolding of the ERK cascade enhances cytosolic ERK activity but inhibits ERK-mediated transcription following angiotensin AT1a receptor stimulation. J Biol Chem 277:9429-9436.
40. Waas WF, Rainey MA, Szafranska AE, and Dalby KN (2003) Two rate-limiting steps in the kinetic mechanism of the serine/threonine specific protein kinase ERK2: a case of fast phosphorylation followed by fast product release. Biochemistry 42:12273-12286.